(3aR,4R,5R,6aS)-六氢-2-氧代-4-[(1E)-3-氧代-5-苯基-1-戊烯基]-2H-环戊并[b]呋喃-5-基 [1,1'-联苯]-4-甲酸酯
- 中文名称:
- (3aR,4R,5R,6aS)-六氢-2-氧代-4-[(1E)-3-氧代-5-苯基-1-戊烯基]-2H-环戊并[b]呋喃-5-基 [1,1'-联苯]-4-甲酸酯
- 中文别名:
- (3aR,4R,5R,6aS)-六氢-2-氧代-4-[(1E)-3-氧代-5-苯基-1-戊烯基]-2H-环戊并[b]呋喃-5-基 [1,1’-联苯]-4-甲酸酯;
[1,1'-联苯]-4-羧酸,(3aR,4R,5R,6aS)-六氢-2-氧代-4-[(1E)-3-氧代-5-苯基-1-戊烯-1-基]-2H-环戊并[b]呋喃-5-基酯;
(3aR,4R,5R,6aS)-六氢-2-氧代-4-[(1E)-3-氧代-5-苯基-1-戊烯基]-2H-环戊并[b]呋喃-5-基 [1,1'-联苯]-4-甲酸酯;
oxirane, 2,2'-[oxybis[(1-methyl-2,1-ethanediyl)oxymethylene]]bis-;
2,2'-[oxybis(propane-1,2-diyloxymethanediyl)]dioxirane;
ciclopirox ethanolamine;
6-cyclohexyl-1-hydroxy-4-methylpyridin-2(1H)-one-2-aminoethanol (1:1);
ciclopirox olami
- 英文名称:
- [1,1'-Biphenyl]-4-carboxylicacid,(3aR,4R,5R,6aS)-hexahydro-2-oxo-4-[(1E)-3-oxo-5-phenyl-1-penten-1-yl]-2H-cyclopenta[b]furan-5-ylester
- 英文别名:
- (3aR,4R,5R,6aS)-2-Oxo-4-[(1E)-3-oxo-5-phenyl-1-penten-1-yl]hexahy dro-2H-cyclopenta[b]furan-5-yl 4-biphenylcarboxylate;
ISOALANTOLACTONE (RG);
isolantolactone;
Naphtho[2,3-b]furan-2(3H)-one,decahydro-8a;
ISOHELENIN;
methyl-3,5-bis(methylene)-,(3aR,4aS,8aR,9aR);
(3ar,4as,8ar,9ar)-8a-methyl-3,5-dimethylene-decahydro-naphtho[2,3-b]furan-2-one;
(3aR,4R,5R,6aS)-2-oxo-4-((E)-3-oxo-4-(3-(trifluoromethyl)phenoxy)but-1-en-1-yl)hexahydro-2H-cyclopenta[b]furan-5-yl [1,1'-biphenyl]-4-carboxylate;
ISOALANTOACTONE;
(3aR,4R,5R,6aS)-2-oxo-4-((E)-3-oxo-4-(3-(trifluoromethyl)phenoxy)but-1-enyl)hexahydro-2H-cyclopenta[b]furan-5-yl biphenyl-4-carboxylate;
(3aR,4R,5R,6aS)-4-(3-oxo-5-phenyl-1E-pentenyl)-5-(4-phenylbenzoyloxy)-hexahydro-2H-cyclopenta[b]furan-2-one;
(3aR,4R,5R,6aS)-2-oxo-4-((E)-3-oxo-5-phenylpent-1-enyl)hexahydro-2H-cyclopenta[b]furan-5-yl biphenyl-4-carboxylate;
(3aR,4aS,8aR,9aR)-decahydro-8a-methyl-3,5-dimethylidenenaphtho[2,3-b]furan-2(3H)-one;
[1,1'-biphenyl]-4-carboxylic acid (3aR,4R,5R,6aS)-hexahydro-2-oxo-4-[(1E)-3-oxo-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]-2H-cyclopenta[b]furan-5-yl ester;
(1S,5R,6R,7R)-6-(3-oxo-5-phenyl-1E-pentenyl)-7-<(4-phenylbenzoyl)oxy>-2-oxabicyclo<3.3.0>octan-3-one
- CAS No.:
- 41639-72-9
- 分 子 式:
-
C31H28O5
- 分 子 量:
- 480.55
- 精确分子量:
- 480.19400
- PSA:
- 69.67000
- InChI:
- InChI=1/C31H28O5/c32-25(16-11-21-7-3-1-4-8-21)17-18-26-27-19-30(33)35-29(27)20-28(26)36-31(34)24-14-12-23(13-15-24)22-9-5-2-6-10-22/h1-10,12-15,17-18,26-29H,11,16,19-20H2/b18-17+/t26-,27-,28-,29+/m1/s1 3
- 分子结构式:
-

- SDS:
- 查看
(3aR,4R,5R,6aS)-六氢-2-氧代-4-[(1E)-3-氧代-5-苯基-1-戊烯基]-2H-环戊并[b]呋喃-5-基 [1,1'-联苯]-4-甲酸酯 物化性质
- 密度:
- 1.26
- 沸点:
- 695.232ºC at 760 mmHg
- 闪点:
- 294.694ºC
- 折射率:
- 1.632
(3aR,4R,5R,6aS)-六氢-2-氧代-4-[(1E)-3-氧代-5-苯基-1-戊烯基]-2H-环戊并[b]呋喃-5-基 [1,1'-联苯]-4-甲酸酯 上游产品
2-氧代-4-苯丁基磷酸二甲酯
(3aR,4R,5R,6aS)-4-醛基六氢-2-氧代-2H-环戊并[b]呋喃-5-基 [1,1'-联苯]-4-甲酸酯
(3aR,4S,5R,6aS)-(-)-六氢-4-(羟甲基)-2-氧代-2H-环戊并[b]呋喃-5-基 1,1'-联苯-4-甲酸酯
2-氧代-4-苯丁基磷酸二甲酯
(3aR,4R,5R,6aS)-4-醛基六氢-2-氧代-2H-环戊并[b]呋喃-5-基 [1,1'-联苯]-4-甲酸酯
(3aR,4S,5R,6aS)-(-)-六氢-4-(羟甲基)-2-氧代-2H-环戊并[b]呋喃-5-基 1,1'-联苯-4-甲酸酯
(3aR,4R,5R,6aS)-六氢-2-氧代-4-[(1E)-3-氧代-5-苯基-1-戊烯基]-2H-环戊并[b]呋喃-5-基 [1,1'-联苯]-4-甲酸酯 下游产品
拉坦前列腺素(游离酸)
(+)-(3aR,4R,5r,6aS)-六氢-5-羟基-4-[(1E,3R)-3-羟基-5-苯基-1-戊烯基]-2H-环戊并[b]呋喃-2-酮
拉坦前列腺素内半缩醛; (3aR,4R,5R,6aS)-六氢-4-[(3R)-3-羟基-5-苯基戊基]-2H-环戊并[b]呋喃-2,5-二醇
拉坦前列素
拉坦前列腺素内酯二醇; (3aR,4R,5R,6aS)-六氢-5-羟基-4-[(3R)-3-羟基-5-苯基戊基]-2H-环戊并[b]呋喃-2-酮
拉坦前列腺素(游离酸)
(+)-(3aR,4R,5r,6aS)-六氢-5-羟基-4-[(1E,3R)-3-羟基-5-苯基-1-戊烯基]-2H-环戊并[b]呋喃-2-酮
拉坦前列腺素内半缩醛; (3aR,4R,5R,6aS)-六氢-4-[(3R)-3-羟基-5-苯基戊基]-2H-环戊并[b]呋喃-2,5-二醇
拉坦前列素
拉坦前列腺素内酯二醇; (3aR,4R,5R,6aS)-六氢-5-羟基-4-[(3R)-3-羟基-5-苯基戊基]-2H-环戊并[b]呋喃-2-酮